152 related articles for article (PubMed ID: 34953081)
1. Identification and validation of PGLS as a metabolic target for early screening and prognostic monitoring of gastric cancer.
Yuan X; Xiao Y; Luo Y; Wei C; Wang J; Huang J; Liao W; Song S; Jiang Z
J Clin Lab Anal; 2022 Feb; 36(2):e24189. PubMed ID: 34953081
[TBL] [Abstract][Full Text] [Related]
2. NAD(P)-dependent steroid dehydrogenase-like protein and neutral cholesterol ester hydrolase 1 serve as novel markers for early detection of gastric cancer identified using quantitative proteomics.
Xiao Y; Xie J; Liu L; Huang W; Han Q; Qin J; Liu S; Jiang Z
J Clin Lab Anal; 2021 Feb; 35(2):e23652. PubMed ID: 33219617
[TBL] [Abstract][Full Text] [Related]
3. Overexpression of Copines-1 is associated with clinicopathological parameters and poor outcome in gastric cancer.
Yang J; Wang Y; Ge R; Jia X; Ge C; Cen Y; Pan D
J Clin Lab Anal; 2022 Nov; 36(11):. PubMed ID: 36310511
[TBL] [Abstract][Full Text] [Related]
4. Low expression of MAP1LC3B, associated with low Beclin-1, predicts lymph node metastasis and poor prognosis of gastric cancer.
Yu S; Li G; Wang Z; Wang Z; Chen C; Cai S; He Y
Tumour Biol; 2016 Nov; 37(11):15007-15017. PubMed ID: 27655288
[TBL] [Abstract][Full Text] [Related]
5. Up-regulated Wnt1-inducible signaling pathway protein 1 correlates with poor prognosis and drug resistance by reducing DNA repair in gastric cancer.
Zhang LH; Wang Y; Fan QQ; Liu YK; Li LH; Qi XW; Mao Y; Hua D
World J Gastroenterol; 2019 Oct; 25(38):5814-5825. PubMed ID: 31636474
[TBL] [Abstract][Full Text] [Related]
6. Myofibrillogenesis regulator-1 overexpression is associated with poor prognosis of gastric cancer patients.
Guo J; Dong B; Ji JF; Wu AW
World J Gastroenterol; 2012 Oct; 18(38):5434-41. PubMed ID: 23082061
[TBL] [Abstract][Full Text] [Related]
7. FLAD1 is up-regulated in Gastric Cancer and is a potential prediction of prognosis.
Hu P; Pan Y; Wang C; Zhang W; Huang H; Wang J; Zhang N
Int J Med Sci; 2020; 17(12):1763-1772. PubMed ID: 32714079
[No Abstract] [Full Text] [Related]
8. High expressions of galectin-1 and VEGF are associated with poor prognosis in gastric cancer patients.
Chen J; Tang D; Wang S; Li QG; Zhang JR; Li P; Lu Q; Niu G; Gao J; Ye NY; Wang DR
Tumour Biol; 2014 Mar; 35(3):2513-9. PubMed ID: 24241899
[TBL] [Abstract][Full Text] [Related]
9. Identification of candidate biomarkers that involved in the epigenetic transcriptional regulation for detection gastric cancer by iTRAQ based quantitative proteomic analysis.
Jiang Z; Sun X; Zhang Q; Ji X; Yu Q; Huang T; Chen D; Chen H; Mei X; Wang L; He L; Fang J; Hou L; Wang L
Clin Chim Acta; 2017 Aug; 471():29-37. PubMed ID: 28502558
[TBL] [Abstract][Full Text] [Related]
10. Overexpression of YKL-40 is an independent prognostic marker in gastric cancer.
Bi J; Lau SH; Lv ZL; Xie D; Li W; Lai YR; Zhong JM; Wu HQ; Su Q; He YL; Zhan WH; Wen JM; Guan XY
Hum Pathol; 2009 Dec; 40(12):1790-7. PubMed ID: 19765801
[TBL] [Abstract][Full Text] [Related]
11. High-Expression HBO1 Predicts Poor Prognosis in Gastric Cancer.
Wang Y; Chen S; Tian W; Zhang Q; Jiang C; Qian L; Liu Y
Am J Clin Pathol; 2019 Sep; 152(4):517-526. PubMed ID: 31247063
[TBL] [Abstract][Full Text] [Related]
12. Increased expression of phospho-acetyl-CoA carboxylase protein is an independent prognostic factor for human gastric cancer without lymph node metastasis.
Fang W; Cui H; Yu D; Chen Y; Wang J; Yu G
Med Oncol; 2014 Jul; 31(7):15. PubMed ID: 24924473
[TBL] [Abstract][Full Text] [Related]
13. Abnormal expression of adhesion protein Bves is associated with gastric cancer progression and poor survival.
Luo D; Huang H; Lu ML; Zhao GF; Chang J; Zheng MY; Wang Y
Pathol Oncol Res; 2012 Apr; 18(2):491-7. PubMed ID: 22109561
[TBL] [Abstract][Full Text] [Related]
14. High expression of MRE11 correlates with poor prognosis in gastric carcinoma.
Li J; Su T; Yang L; Zhang C; He Y
Diagn Pathol; 2019 Jun; 14(1):60. PubMed ID: 31221177
[TBL] [Abstract][Full Text] [Related]
15. Quantitative proteomic analysis reveals that proteins required for fatty acid metabolism may serve as diagnostic markers for gastric cancer.
Jiang Z; Shen H; Tang B; Yu Q; Ji X; Wang L
Clin Chim Acta; 2017 Jan; 464():148-154. PubMed ID: 27884752
[TBL] [Abstract][Full Text] [Related]
16. Decreased expression of SEMA3A is associated with poor prognosis in gastric carcinoma.
Tang C; Gao X; Liu H; Jiang T; Zhai X
Int J Clin Exp Pathol; 2014; 7(8):4782-94. PubMed ID: 25197349
[TBL] [Abstract][Full Text] [Related]
17. NEDD9 overexpression correlates with the progression and prognosis in gastric carcinoma.
Shi R; Wang L; Wang T; Xu J; Wang F; Xu M
Med Oncol; 2014 Mar; 31(3):852. PubMed ID: 24469954
[TBL] [Abstract][Full Text] [Related]
18. Relationship between expression of IGFBP7 and clinicopathological variables in gastric cancer.
Sato Y; Inokuchi M; Takagi Y; Otsuki S; Fujimori Y; Yanaka Y; Kobayashi K; Higuchi K; Kojima K; Kawano T
J Clin Pathol; 2015 Oct; 68(10):795-801. PubMed ID: 26043748
[TBL] [Abstract][Full Text] [Related]
19. Increased expression of DLX2 correlates with advanced stage of gastric adenocarcinoma.
Tang P; Huang H; Chang J; Zhao GF; Lu ML; Wang Y
World J Gastroenterol; 2013 May; 19(17):2697-703. PubMed ID: 23674878
[TBL] [Abstract][Full Text] [Related]
20. Elevated spondin-2 expression correlates with progression and prognosis in gastric cancer.
Jin C; Lin JR; Ma L; Song Y; Shi YX; Jiang P; Dong Y; Li XS
Oncotarget; 2017 Feb; 8(6):10416-10424. PubMed ID: 28060752
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]